u/EducationalMango1320

Imagine running a high-tech fintech company but completely messing up how you count your money. That is exactly what a major lawsuit claims Ryvyl ($RVYL) did. In early 2023, they had to admit to everyone that their previous financial numbers were totally wrong, meaning they had been inflating their sales and hiding how much cash they were actually losing. 

The stock dropped instantly, their CFO packed his bags and quit, and investors were left with the damage.

 To clear their name and settle the fight, they agreed to a $300,000 cash settlement. If you bought or held shares between January 29, 2021, and April 20, 2023, you are on the list of people who can get a refund.

The best part about this recovery is that they are officially accepting Late Claims right now. Even though the original deadlines have passed, the people handling the funds are still reviewing and approving late applications. The payout is estimated at around $0.04 per share, which is definitely worth a few minutes of your time if you had a standard position.

It's wild to see how fast a company falls apart once they confess that their bookkeeping can't be trusted. I'm already digging through my old accounts to make sure my late form goes in before the door locks completely.

 Did any of you actually trust their fintech hype before the numbers broke, or did you sell your shares right when the CFO quit?

Imagine running a high-tech fintech company but completely messing up how you count your money. That is exactly what a major lawsuit claims Ryvyl ($RVYL) did. In early 2023, they had to admit to everyone that their previous financial numbers were totally wrong, meaning they had been inflating their sales and hiding how much cash they were actually losing. 

The stock dropped instantly, their CFO packed his bags and quit, and investors were left with the damage.

 To clear their name and settle the fight, they agreed to a $300,000 cash settlement. If you bought or held shares between January 29, 2021, and April 20, 2023, you are on the list of people who can get a refund.

The best part about this recovery is that they are officially accepting Late Claims right now. Even though the original deadlines have passed, the people handling the funds are still reviewing and approving late applications. The payout is estimated at around $0.04 per share, which is definitely worth a few minutes of your time if you had a standard position.

It's wild to see how fast a company falls apart once they confess that their bookkeeping can't be trusted. I'm already digging through my old accounts to make sure my late form goes in before the door locks completely.

 Did any of you actually trust their fintech hype before the numbers broke, or did you sell your shares right when the CFO quit?

Promoted environmental compliance → ✅ Emissions standards marketing → ✅ Defeat devices installed in engines → ❌ DOJ building case for years → ❌ December 22, 2023: $1.6B Clean Air Act penalty announced → ❌ $CMI drops 2.87% same day → ❌ $990M market cap wiped → ❌ Same playbook as Volkswagen Dieselgate → ❌ $1.6M investor settlement → ✅ Late claims still open → ✅

Eligible if you held $CMI between February 11, 2019 and December 21, 2023. Payout: ~$0.22/share. Court hearing May 21.

VW paid $30B+. Cummins paid $1.6B. Same defeat device mechanism. Anyone here follow the DOJ investigation before the December 2023 announcement?

Same mechanism. Different industry. Much less coverage.

VW installed defeat devices that reduced emissions during testing while polluting more during normal operation. Paid $30B+ in penalties and settlements.

Cummins did the same thing, defeat devices in diesel and natural gas engines used in commercial trucks and industrial equipment. Engines that people in this community know well, work on, or operate daily.

The DOJ announced a $1.6 billion Clean Air Act penalty on December 22, 2023. Same day $CMI dropped nearly 3%, wiping out $990 million in market value.

Cummins had been publicly promoting its environmental compliance and emissions standards the whole time.

Investor settlement: $1.6M. Claim deadline already passed but late claims still being accepted.

Eligible if you held $CMI between February 11, 2019 and December 21, 2023. Payout: ~$0.22/share.

Anyone here work on Cummins engines during this period. Was anything about emissions performance raising flags before the DOJ announcement?

March 2022: reports come in that Shoals' wire harnesses are shrinking back and exposing live conductors at solar installations. Fire risk. Injury risk.

December 2022: secondary offering, 26 million shares. Product safety still being promoted. March 2023: another secondary offering. August 2023: first public acknowledgment, less than $10M disclosed. November 2023: actual estimate, $59.7M to $184.9M. Stock drops. November 2024: lower end raised to $73M.

Court approved the $70M settlement. Applications open now.

Eligible if you held $SHLS between May 17, 2022 and May 7, 2024. Payout: ~$0.34/share.

Anyone here work with Shoals' BLA system during this period, was the shrinkback issue being discussed on job sites before August 2023?

Remember when Hertz ($HTZ) started buying thousands of electric vehicles (EVs) and told us it was going to revolutionize the rental market? It turns out they heavily downplayed how fast those cars were losing value and hid the fact that they were going to take huge losses trying to get rid of them. When the truth came out about the actual car depreciation costs, the stock took a massive beating. To resolve this mess with shareholders, Hertz has agreed to a $154 million settlement. If you bought or held shares between January 6, 2023, and April 24, 2024, you are eligible for a piece of the cash.

The case is currently moving forward, and they are in the Tentative Settlement phase. Since the huge $154 million pool was officially agreed upon, the legal process is actively sorting out the claims. It takes just a quick look into your old investing apps to find your trade statements from late 2023 or early 2024 to make sure you are ready for the upcoming shareholder recovery. I’m already pulling up my old account logs to make sure my paperwork is ready for the claims process.

Did any of you actually rent one of their EVs back then?

For anyone not familiar with the ASPI situation, here's the context that makes it relevant to us.

What HALEU actually is: High-Assay Low-Enriched Uranium, enriched to between 5% and 20% U-235, is the fuel that powers next-generation reactor designs. TerraPower's Natrium reactor. X-energy's Xe-100. Kairos Power. The entire advanced reactor pipeline depends on a reliable HALEU supply chain that essentially doesn't exist yet at commercial scale. The US has been almost entirely dependent on Russian sources. Domestic enrichment capacity is one of the most critical bottlenecks in the entire advanced nuclear buildout.

Where ASPI fit in: ASP Isotopes was positioning its quantum enrichment technology as a solution to exactly that problem. Laser-based isotope separation, faster, cheaper, more efficient than centrifuge enrichment. They announced milestones, signed a term sheet with TerraPower, and raised $18.6 million from investors in November 2024 on the back of that story.

What Fuzzy Panda found: The technology had never been tested on uranium. Not by ASPI. Not by Klydon, the South African company ASPI acquired the technology from. Former Klydon scientists said they didn't believe the process would work on uranium at all. The TerraPower term sheet was allegedly non-binding and possibly used to pressure TerraPower's actual suppliers rather than signal genuine commitment.

November 27, 2024: CEO Paul Mann confirmed on a fireside chat, the one ASPI arranged to defend itself against the Fuzzy Panda report, that the company had never enriched uranium and still needed to test whether the process worked on it.

Stock dropped ~38% across two days. Case settled April 2026, and claims already being accepted. Eligible if you held $ASPI between September 26 and November 26, 2024.

The HALEU supply chain problem is real and urgent. ASPI just wasn't the solution they claimed to be.

The domestic HALEU enrichment gap is still very much unsolved. Anyone here tracking which players are actually making progress on this?

Hey guys, if you missed it, Adapthealth settled $35 million with investors over boosted revenue by overbilling Medicare for diabetes products and giving a false picture of growth. And, the deadline to file a claim and get payment is July 2, 2026

In a nutshell, in 2023, AdaptHealth was accused of misleading investors about Medicare reimbursement practices and the sustainability of growth in its diabetes segment. In short, the company allegedly failed to disclose that part of its CGM-related revenue growth relied on billing practices tied to higher reimbursement codes, which later came under increased scrutiny and pressured margins and guidance. Following the news, the stock declined, and investors filed a lawsuit.

After this news came out, the stock dropped 27%, and investors filed a lawsuit for their losses.

Now, the good news is that the company agreed to settle $35 million with them, and investors have until July 2, 2026 to submit a claim. 

So, if you invested in $AHCO when all of this happened, you can check the details and file your claim here.

Anyway, has anyone here invested in $AHCO at that time? How much were your losses, if so?

Hey guys, if you missed it, Lifecore Biomedical settled $3.75 million with investors over accounting and internal control issues. And, the deadline to file a claim and get payment is July 7, 2026

In a nutshell, in 2023, Lifecore Biomedical was accused of misleading investors about its inventory management, accounting practices, and internal financial controls. In short, the company allegedly failed to disclose persistent accounting deficiencies and inventory-related issues that later led to delayed filings, loan covenant breaches, default notices, and disclosures of material weaknesses in internal controls. Following this, the stock declined, and investors filed a lawsuit to recover losses.

After this news came out, the stock dropped, and investors filed a lawsuit for their losses.

Now, the good news is that the company agreed to settle $3.75 million with them, and investors have until July 7, 2026 to submit a claim. 

So, if you invested in $LFCR when all of this happened, you can check the details and file your claim here.

Anyway, has anyone here invested in $LFCR at that time? How much were your losses, if so?

This one has more layers than most.

Maison Solutions is an Asian specialty grocery chain in the Los Angeles area, HK Good Fortune Supermarkets, Hong Kong Supermarkets. IPO'd October 5, 2023 at $4.00 per share. Standard small-cap grocery story on the surface.

Seventy-one days later, Hindenburg Research published a report. Here's what they found:

Layer 1 — The related-party problem: Maison described XHJC Holdings as a vendor and centralized supplier in its IPO filings. What it didn't disclose: XHJC was also a related party. The IPO proceeds were also earmarked to acquire stores from the CEO's own spouse and from the CEO himself, details that were in the filings but framed in a way investors say obscured the full picture.

Layer 2 — The EB-5 visa fraud allegations: Hindenburg alleged that CEO John Xu, J&C International Group, and Hong Kong Supermarkets had previously been accused of using supermarkets as a front to defraud the EB-5 visa program, a federal program that grants green cards to foreign investors who create US jobs. None of those prior allegations appeared in the IPO disclosures.

Layer 3 — The WhatsApp pump: Hindenburg also alleged Maison's stock was being actively promoted in WhatsApp chat rooms to drive buying activity post-IPO.

December 15, 2023: Report drops. $MSS falls 83.6% in a single session, from above IPO price to $2.50.

Investors filed suit in January 2024. Tentative settlement reached February 2026. Applications open now while terms are finalized.

Eligible if you held $MSS between October 5 and December 15, 2023.

EB-5 visa fraud allegations + undisclosed related-party dealings + WhatsApp pumping in one 71-day IPO window is a remarkable combination. Anyone here follow Hindenburg's small-cap reports closely enough to have caught this one?

This one has more layers than most.

Maison Solutions is an Asian specialty grocery chain in the Los Angeles area, HK Good Fortune Supermarkets, Hong Kong Supermarkets. IPO'd October 5, 2023 at $4.00 per share. Standard small-cap grocery story on the surface.

Seventy-one days later, Hindenburg Research published a report. Here's what they found:

Layer 1 — The related-party problem: Maison described XHJC Holdings as a vendor and centralized supplier in its IPO filings. What it didn't disclose: XHJC was also a related party. The IPO proceeds were also earmarked to acquire stores from the CEO's own spouse and from the CEO himself, details that were in the filings but framed in a way investors say obscured the full picture.

Layer 2 — The EB-5 visa fraud allegations: Hindenburg alleged that CEO John Xu, J&C International Group, and Hong Kong Supermarkets had previously been accused of using supermarkets as a front to defraud the EB-5 visa program, a federal program that grants green cards to foreign investors who create US jobs. None of those prior allegations appeared in the IPO disclosures.

Layer 3 — The WhatsApp pump: Hindenburg also alleged Maison's stock was being actively promoted in WhatsApp chat rooms to drive buying activity post-IPO.

December 15, 2023: Report drops. $MSS falls 83.6% in a single session, from above IPO price to $2.50.

Investors filed suit in January 2024. Tentative settlement reached February 2026. Applications open now while terms are finalized.

Eligible if you held $MSS between October 5 and December 15, 2023.

EB-5 visa fraud allegations + undisclosed related-party dealings + WhatsApp pumping in one 71-day IPO window is a remarkable combination. Anyone here follow Hindenburg's small-cap reports closely enough to have caught this one?

Here's a timeline that requires some patience to fully appreciate:

July 8, 2014: The New York Times reports suspicious price hikes on Lannett's Digoxin, a heart medication derived from foxglove plants that has existed since the 1700s. Zero R&D costs. Zero innovation. Just a sudden, inexplicable price spike.

July 16, 2014: Connecticut Attorney General subpoenas Lannett over price-fixing.

December 2014: Federal antitrust investigation revealed.

2014–2017: Lannett execs continue telling investors the strong revenue performance is due to, and this is the actual language, "market forces." Meanwhile internal communications show execs coordinating price hikes with competitors, sharing confidential pricing data, and allocating market shares across Doxycycline Monohydrate, Digoxin, and Ursodiol.

October 31, 2017: 45 states file an expanded lawsuit naming Lannett. The "market forces" narrative collapses. $LCI drops 14%. Investor lawsuit follows.

Three years. Three generic drugs. Forty-five states. One remarkably durable cover story.

$5.75M settlement. Late claims still being considered.

Eligible if you held $LCI between July 15, 2014 and January 30, 2018. Payout: ~$0.16/share.

"Market forces" on a drug that's been generic since the 1700s is a bold choice of words, anyone here follow the generic drug price-fixing investigations of that era? This was one of dozens of companies caught up in it.

For anyone who held $SEDG during 2023, the settlement has received court approval. That means the claims process is now moving forward.

The case was about what SolarEdge was telling investors about its European business while channel inventory was quietly building. Between February and September 2023, the company consistently described European demand as strong and inventory levels as low. Finished-goods inventory went from $202 million at the start of 2023 to $731 million by Q3, a detail that didn't make it into investor communications until it was unavoidable.

Two disclosures confirmed the gap:

August 1, 2023: excess inventory in Europe acknowledged. Stock fell 18.3%.

October 19, 2023: substantial distributor cancellations and missed guidance disclosed. Stock fell another 27.2%.

A settlement was reached in March 2026. Court approval has now been granted.

If you held $SEDG between February 23, 2023 and October 19, 2023, you can file your claim now.

Anyone here follow the European solar demand cycle closely, was the inventory buildup visible from the distributor side before October?

For anyone who held $SEDG during 2023, the settlement has received court approval. That means the claims process is now moving forward.

The case was about what SolarEdge was telling investors about its European business while channel inventory was quietly building. Between February and September 2023, the company consistently described European demand as strong and inventory levels as low. Finished-goods inventory went from $202 million at the start of 2023 to $731 million by Q3, a detail that didn't make it into investor communications until it was unavoidable.

Two disclosures confirmed the gap:

August 1, 2023: excess inventory in Europe acknowledged. Stock fell 18.3%.

October 19, 2023: substantial distributor cancellations and missed guidance disclosed. Stock fell another 27.2%.

A settlement was reached in March 2026. Court approval has now been granted.

If you held $SEDG between February 23, 2023 and October 19, 2023, you can file your claim now.

Anyone here follow the European solar demand cycle closely, was the inventory buildup visible from the distributor side before October?

If you’ve been following biotech lately, the Applied Therapeutics ($APLT) situation is a textbook case of "what management says" vs. "what the FDA actually sees." 

For most of 2024, the company was pumping up Govorestat, claiming their Phase III trials were a huge success and that FDA approval was basically a lock.

 But behind the scenes, there was a massive gap between their public hype and the actual quality of their data.

Long story short: In early 2024, the company told investors that its clinical data for galactosemia treatment was strong and that development remained on track. However, in November 2024, the FDA issued a Complete Response Letter citing serious deficiencies, including missing data and protocol errors. Just a month later, the FDA sent an additional warning letter criticizing the company for failing to correct issues identified in prior trials. 

Once the market learned about the dosing errors and protocol inconsistencies, $APLT stock collapsed more than 80%, and investors filed a lawsuit. The company has now agreed to a $15 million settlement to resolve the claims

If you traded $APLT between January 3, 2024, and December 2, 2024, you’re likely eligible.

The claims process is already moving forward, including late claims and investor notices.  If you were affected by that decline, now is a good time to check your eligibility and file a claim so you don’t miss the chance to recover part of your losses.

If you’ve been following biotech lately, the Applied Therapeutics ($APLT) situation is a textbook case of "what management says" vs. "what the FDA actually sees." 

For most of 2024, the company was pumping up Govorestat, claiming their Phase III trials were a huge success and that FDA approval was basically a lock.

 But behind the scenes, there was a massive gap between their public hype and the actual quality of their data.

Long story short: In early 2024, the company told investors that its clinical data for galactosemia treatment was strong and that development remained on track. However, in November 2024, the FDA issued a Complete Response Letter citing serious deficiencies, including missing data and protocol errors. Just a month later, the FDA sent an additional warning letter criticizing the company for failing to correct issues identified in prior trials. 

Once the market learned about the dosing errors and protocol inconsistencies, $APLT stock collapsed more than 80%, and investors filed a lawsuit. The company has now agreed to a $15 million settlement to resolve the claims

If you traded $APLT between January 3, 2024, and December 2, 2024, you’re likely eligible.

The claims process is already moving forward, including late claims and investor notices.  If you were affected by that decline, now is a good time to check your eligibility and file a claim so you don’t miss the chance to recover part of your losses.

Hey guys, if you missed it, TaskUs settled $17.5 million with investors over allegations it misled the market about employee attrition, workplace culture, and operational risks. And, I just found out that they’re accepting claims even though the deadline has passed. 

Quick recap: In 2022, TaskUs was accused of overstating employee retention and presenting a misleading picture of its workplace environment following its IPO. In short, the company promoted itself as a high-growth outsourcing business with low attrition and a unique culture, but reports later claimed that more than half of new employees were leaving within their first 60 days. Investors also alleged that TaskUs encouraged employees to submit Glassdoor reviews during training to artificially boost its ratings, while insiders sold hundreds of millions in shares through a secondary offering.

After this news came out, the stock dropped 20%, and investors filed a lawsuit for their losses.

Now, the good news is that the company agreed to settle $17.5 million with them, and even though the deadline has passed recently, they’re accepting late claims.

So, if you invested in $TASK when all of this happened, you can still check the details and file your claim here.

Anyway, has anyone here invested in $TASK at that time? How much were your losses, if so?

Hey guys, if you missed it, TaskUs settled $17.5 million with investors over allegations it misled the market about employee attrition, workplace culture, and operational risks. And, I just found out that they’re accepting claims even though the deadline has passed. 

Quick recap: In 2022, TaskUs was accused of overstating employee retention and presenting a misleading picture of its workplace environment following its IPO. In short, the company promoted itself as a high-growth outsourcing business with low attrition and a unique culture, but reports later claimed that more than half of new employees were leaving within their first 60 days. Investors also alleged that TaskUs encouraged employees to submit Glassdoor reviews during training to artificially boost its ratings, while insiders sold hundreds of millions in shares through a secondary offering.

After this news came out, the stock dropped 20%, and investors filed a lawsuit for their losses.

Now, the good news is that the company agreed to settle $17.5 million with them, and even though the deadline has passed recently, they’re accepting late claims.

So, if you invested in $TASK when all of this happened, you can still check the details and file your claim here.

Anyway, has anyone here invested in $TASK at that time? How much were your losses, if so?

We’ve all seen companies "adjust" their numbers, but what happened with Luna Innovations ($LUNA) was on another level. For nearly two years, they told us their growth was solid and their internal controls were "effective." 

It turns out, that was a complete myth. In early 2024, the house of cards collapsed when they admitted they had been messing up their revenue reports since all the way back in Q1 2022.

The fallout was absolute chaos:

• The Stock: Once the truth hit, $LUNA crashed over 80% from its peak, erasing nearly $290 million of our money.
• The Bosses Got Fired: It wasn't just a small mistake. The board admitted their internal checks were a total failure. The entire leadership team, the CEO, CFO, and CTO, were either forced to quit or fired "for cause" (which is the corporate way of saying they got kicked out for doing a bad job).
• The Reality: They started missing SEC deadlines and admitted their books couldn't be trusted for years.

So, if you bought or held $SGLY between May 16, 2022, and April 19, 2024, you are right in the middle of this mess. 

The most important part: Late Claims are currently being considered. Even if you think you missed the boat to hold them accountable, the door is still open to file for compensation.

My advice: Don’t let this opportunity pass. If you were holding during this meltdown, go find your trade records and get your Late Claim in ASAP.